HOME >> BIOLOGY >> NEWS
Antioxidants during pregnancy may help prevent birth defects tied to alcohol

CHAPEL HILL -- Pregnant women who abuse alcohol may reduce the risk of birth defects in their babies by taking antioxidants during pregnancy, a University of North Carolina at Chapel Hill study indicates.

The new research found a 36 percent reduction in limb malformations in the offspring of pregnant mice exposed to ethanol and at the same time given a newly developed antioxidant compound called EUK-134.

The study appears on-line Friday (June 18) in FASEB-J, the journal of the Federation of American Societies for Experimental Biology.

"What makes this study unique is that it shows for the first time that giving antioxidants to a pregnant mother at the same time she's exposed to alcohol can diminish the incidence of major malformations," said Dr. Kathleen K. Sulik, professor of cell and developmental biology at UNC's School of Medicine.

Antioxidants protect key cellular components by neutralizing the damaging effects of free radicals, natural byproducts of cell metabolism. Free radicals form when oxygen is metabolized, or burned off, by the body. They travel through cells, disrupting the structure of other molecules, causing cellular damage. Such cell damage is believed to contribute to aging and various health problems. Examples of antioxidants are selenium, vitamin C and E, zinc and superoxide dismutase (or SOD), a zinc- and copper- or manganese-containing enzyme that reacts with superoxide radicals to convert them to less dangerous chemical entities.

Dietary antioxidants have attracted considerable interest in the popular press as potential treatments for cancer, atherosclerosis, chronic inflammatory disease and aging.

Sulik, a member of the university's Bowles Center for Alcohol Studies, said a major focus of her research has been cellular mechanisms involved in birth defect formation, particularly those linked to ethanol exposure, such as fetal alc
'"/>


18-Jun-2004


Page: 1 2 3 4

Related biology news :

1. Supplementing Diet With Fruits And Vegetables, Rather Than Vitamins, Provides Needed "Antioxidants"
2. In New Alzheimers Studies, Lab Tests Show Vitamin E And Other Antioxidants Preventing Brain Cell Death
3. Antioxidants May Reduce Harmful Complications Of Diabetes
4. Free Radicals Implicated In Impaired Lung Function; Damage May Be Mitigated By Certain Antioxidants
5. Anxiety during pregnancy affects child behavior
6. Deserts and rainforests are equally productive during drought
7. Germans must research the history of reproductive medicine during the Nazi era
8. Gene therapy tested to protect bone marrow during chemotherapy
9. Researchers find no link between alcohol consumption during pregnancy and asthma during childhood
10. Chemical reaction in birds provides sense of direction during migratory flights
11. AIDS drug helps to keep HBV at bay during chemotherapy for breast cancer

Post Your Comments:
(Date:10/15/2014)... increased resistance to bacterial pneumonia in female mice to ... , Females are naturally more resistant to respiratory infections ... shown that increased resistance to bacterial pneumonia in female ... 3 (NOS3). They also show that this enzyme is ... hormone estrogen. , The team, lead by Professor Lester ...
(Date:10/14/2014)... Cancer Research shows SIRT6—a protein known to inhibit ... development of skin cancers by turning on an enzyme ... cells. , Previously considered protective, SIRT6 is part of ... regulate genomic stability and prevent some of the genetic ... which can lead to cancer. This study, in the ...
(Date:10/14/2014)... October 14, 2014 – High doses of fish oil supplements, ... a common type of irregular heartbeat in which the heart ... results of the AFFORD trial led by the Montreal Heart ... College of Cardiology on October 7th. , For the ... therapy were randomly assigned to 4 grams of fish oil ...
Breaking Biology News(10 mins):Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
(Date:10/22/2014)... 21, 2014 Shimadzu Scientific Instruments introduces ... tool for the pain management and clinical markets. The ... and review by allowing users to highlight and review ... , QuantAnalytics allows analysts to filter results by group ... processing by eliminating the need to sift through analytes ...
(Date:10/22/2014)... Hill, SC (PRWEB) October 22, 2014 ... expansion of its cardiovascular pharmacogenetics menu, which enables ... patient outcomes. With PCLS’s evidence-based results, healthcare ... needs and optimize their therapy, while minimizing risks ... In the U.S., according to the FDA [1] ...
(Date:10/22/2014)... 2014 Research and Markets  has announced ... Material, by Application, Geography - Global Analysis and Forecast ... Organic electronics, also called as polymer electronics ... which deals with small conductive molecules and electrically conductive ... and polymers are carbon based, made using synthetic strategies ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
Breaking Biology Technology:Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: